• Note d'application

Tamoxifen

Tamoxifen

  • Waters Corporation
Healthcare and medicine concept - woman holding pink breast cancer awareness ribbon

This is an Application Brief and does not contain a detailed Experimental section.

Abstract

Ths application brief highlights the analysis of Tamoxifen using Symmetry Columns.

Introduction

Tamoxifen Citrate is studied in this application brief.

Experimental

HPLC Method

Column:

Symmetry C8, 3.9 x 150 mm, 5 μm (p/n:WAT046970)

Mobile phase:

50 mM potassium phosphate, pH 3/acetonitrile 55:45

Flow rate:

1.0 mL/min

Injection volume:

5 μL of 100 μg/mL

Detection:

UV @ 254 nm

USP Tailing Factors

1. 1.3 

Results and Discussion

Featured Products

WA31763.162, June 2003

Haut de la page Haut de la page